IntellAif Information

We accelerate drug development by improving the translatibility of preclinical models with AI. Pharmaceutical companies face an enduring challenge: too many promising drug candidates fail in clinical trials due to a lack of efficacy. At IntellAif, we are revolutionizing drug development by ensuring the translatability of preclinical models. We use DeepTech to de-risk preclinical investigation. Our X-Bio™ Research Platform and BioSync™ provide state of the art analytics and confidence scores to your preclinical data.